IL13 and familial pancreatic carcinoma: Thus, there is the possibility that IL-13, in addition to imposing direct stimulating effects on pancreatic cancer cell progression, may also contribute to the inhibition of anti-tumor immune mechanisms, thereby facilitating tumor spread.